The Agonists of Peroxisome Proliferator-Activated Receptor-γ for Liver Fibrosis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Agonists of Peroxisome Proliferator-Activated Receptor-γ for Liver Fibrosis
Authors
Keywords
-
Journal
Drug Design Development and Therapy
Volume Volume 15, Issue -, Pages 2619-2628
Publisher
Informa UK Limited
Online
2021-06-18
DOI
10.2147/dddt.s310163
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunity as Cornerstone of Non-Alcoholic Fatty Liver Disease: The Contribution of Oxidative Stress in the Disease Progression
- (2021) Marcello Dallio et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Crosstalk between PPARs and gut microbiota in NAFLD
- (2021) Liwei Wu et al. BIOMEDICINE & PHARMACOTHERAPY
- Identification of Lineage-specific Transcription Factors That Prevent Activation of Hepatic Stellate Cells and Promote Fibrosis Resolution
- (2020) Xiao Liu et al. GASTROENTEROLOGY
- Therapeutic potential of PPARγ natural agonists in liver diseases
- (2020) Liwei Wu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Peroxisome Proliferator-Activated Receptors as a Therapeutic Target in Asthma
- (2020) Oxana Yu. Kytikova et al. PPAR Research
- Bergenin Exerts Hepatoprotective Effects by Inhibiting the Release of Inflammatory Factors, Apoptosis and Autophagy via the PPAR-γ Pathway
- (2020) Shihao Xiang et al. Drug Design Development and Therapy
- Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages
- (2020) Sander Lefere et al. JOURNAL OF HEPATOLOGY
- PPAR-Gamma Agonist Pioglitazone Reduced CD68+ but Not CD163+ Macrophage Dermal Infiltration in Obese Psoriatic Patients
- (2020) Ya. O. Yemchenko et al. PPAR Research
- Loss of Hepatocyte-Specific PPARγ Expression Ameliorates Early Events of Steatohepatitis in Mice Fed the Methionine and Choline-Deficient Diet
- (2020) Jose Cordoba-Chacon PPAR Research
- Efficient drug and gene delivery to liver fibrosis: rationale, recent advances, and perspectives
- (2020) Somayeh Mahdinloo et al. Acta Pharmaceutica Sinica B
- Crocin attenuates CCl4-induced liver fibrosis via PPAR-γ mediated modulation of inflammation and fibrogenesis in rats
- (2020) J Chhimwal et al. HUMAN & EXPERIMENTAL TOXICOLOGY
- The roles of PPARγ and its agonists in autoimmune diseases: A comprehensive review
- (2020) Yu Liu et al. JOURNAL OF AUTOIMMUNITY
- Peroxisome proliferator-activated receptor γ inhibits hepatic stellate cell activation regulated by miR-942 in chronic hepatitis B liver fibrosis
- (2020) Le Tao et al. LIFE SCIENCES
- The role of Peroxisome Proliferator-Activated Receptors (PPAR) in immune responses
- (2020) Anthos Christofides et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Redox Regulation of PPARγ in Polarized Macrophages
- (2020) Verena Trümper et al. PPAR Research
- The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease
- (2020) Divya P. Kumar et al. Scientific Reports
- The T Cell Receptor Immune Repertoire Protects the Liver From Reconsitution
- (2020) Qing Liang et al. Frontiers in Immunology
- Molecular Pathways Modulated by Mesenchymal Stromal Cells and Their Extracellular Vesicles in Experimental Models of Liver Fibrosis
- (2020) Giulia Chiabotto et al. Frontiers in Cell and Developmental Biology
- Molecular Mechanisms That Link Oxidative Stress, Inflammation, and Fibrosis in the Liver
- (2020) Erika Ramos-Tovar et al. Antioxidants
- HCC surveillance after SVR in patients with F3/F4 fibrosis
- (2020) George N. Ioannou JOURNAL OF HEPATOLOGY
- Peroxisome proliferator-activated receptors in the pathogenesis and therapies of liver fibrosis
- (2020) Xin Han et al. PHARMACOLOGY & THERAPEUTICS
- Umbelliferone Ameliorates CCl4-Induced Liver Fibrosis in Rats by Upregulating PPARγ and Attenuating Oxidative Stress, Inflammation, and TGF-β1/Smad3 Signaling
- (2019) Ayman M. Mahmoud et al. INFLAMMATION
- Protective effect of cultured bear bile powder against dimethylnitrosamine-induced hepatic fibrosis in rats
- (2019) Min Zheng et al. BIOMEDICINE & PHARMACOTHERAPY
- The dual PPAR-α/γ agonist saroglitazar ameliorates thioacetamide-induced liver fibrosis in rats through regulating leptin
- (2019) Mirhan N. Makled et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- 15-Deoxy-∆-12,14-Prostaglandin J2 (15d-PGJ2), an Endogenous Ligand of PPAR-γ: Function and Mechanism
- (2019) Jingjing Li et al. PPAR Research
- GDF10 blocks hepatic PPARγ activation to protect against diet-induced liver injury
- (2019) Khrystyna Platko et al. Molecular Metabolism
- Rosiglitazone ameliorates bile duct ligation-induced liver fibrosis by down-regulating NF-κB-TNF-α signaling pathway in a PPARγ-dependent manner
- (2019) Zhuo Wei et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Docosahexaenoic acid inhibits hepatic stellate cell activation to attenuate liver fibrosis in a PPARγ-dependent manner
- (2019) Jianlin He et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Beneficial Effects of the Peroxisome Proliferator-Activated Receptor α/γ Agonist Aleglitazar on Progressive Hepatic and Splanchnic Abnormalities in Cirrhotic Rats with Portal Hypertension
- (2018) Hung-Cheng Tsai et al. AMERICAN JOURNAL OF PATHOLOGY
- rSjP40 protein promotes PPARγ expression in LX-2 cells through microRNA-27b
- (2018) Dandan Zhu et al. FASEB JOURNAL
- Fucosterol Protects against Concanavalin A-Induced Acute Liver Injury: Focus on P38 MAPK/NF-κB Pathway Activity
- (2018) Wenhui Mo et al. Gastroenterology Research and Practice
- Ligand Activation of PPARγ by Ligustrazine Suppresses Pericyte Functions of Hepatic Stellate Cells via SMRT-Mediated Transrepression of HIF-1α
- (2018) Feng Zhang et al. Theranostics
- Exercise rescues the immune response fine-tuned impaired by peroxisome proliferator-activated receptors γ deletion in macrophages
- (2018) Loreana Sanches Silveira et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Docosahexaenoic acid attenuates carbon tetrachloride-induced hepatic fibrosis in rats
- (2017) Jianlin He et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Antifibrotic effect of total flavonoids of Astmgali Radix on dimethylnitrosamine-induced liver cirrhosis in rats
- (2016) Yang Cheng et al. Chinese Journal of Integrative Medicine
- GATA binding protein 3 is correlated with leptin regulation of PPARγ1 in hepatic stellate cells
- (2016) Wei Guan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Galanin receptor 2 mediates antifibrogenic effects of galanin on hepatic stellate cells
- (2016) Lingnan He et al. Experimental and Therapeutic Medicine
- Curcumin regulates peroxisome proliferator-activated receptor-γ coactivator-1α expression by AMPK pathway in hepatic stellate cells in vitro
- (2015) Xuguang Zhai et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Resveratrol Regulates the Quiescence-Like Induction of Activated Stellate Cells by Modulating the PPARγ/SIRT1 Ratio
- (2015) Izabel Cristina Custódio de Souza et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Astaxanthin Inhibits Proliferation and Induces Apoptosis of Human Hepatocellular Carcinoma Cells via Inhibition of Nf-Κb P65 and Wnt/Β-Catenin in Vitro
- (2015) Jingjing Li et al. Marine Drugs
- Astaxanthin Pretreatment Attenuates Hepatic Ischemia Reperfusion-Induced Apoptosis and Autophagy via the ROS/MAPK Pathway in Mice
- (2015) Jingjing Li et al. Marine Drugs
- GATA binding protein 2 mediates leptin inhibition of PPARγ1 expression in hepatic stellate cells and contributes to hepatic stellate cell activation
- (2014) Qian Zhou et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- The protective effects ofAcanthus ilicifoliusalkaloid A and its derivatives on pro- and anti-inflammatory cytokines in rats with hepatic fibrosis
- (2014) Kyi Kyi Wai et al. BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
- Curcumin regulates delta-like homolog 1 expression in activated hepatic stellate cell
- (2014) Jianwei Qiu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Curcumin attenuates angiogenesis in liver fibrosis and inhibits angiogenic properties of hepatic stellate cells
- (2014) Feng Zhang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- microRNA-34a and microRNA-34c promote the activation of human hepatic stellate cells by targeting peroxisome proliferator-activated receptor γ
- (2014) XIAOFEI LI et al. Molecular Medicine Reports
- Hydroxysafflor yellow A suppresses liver fibrosis induced by carbon tetrachloride with high-fat diet by regulating PPAR-γ/p38 MAPK signaling
- (2014) Q. Liu et al. PHARMACEUTICAL BIOLOGY
- Hepatic PPARs: Their Role in Liver Physiology, Fibrosis and Treatment
- (2013) E. Zardi et al. CURRENT MEDICINAL CHEMISTRY
- Anti-fibrotic effects of puerarin on CCl4-induced hepatic fibrosis in rats possibly through the regulation of PPAR-γ expression and inhibition of PI3K/Akt pathway
- (2013) Chao Guo et al. FOOD AND CHEMICAL TOXICOLOGY
- Nuclear control of inflammation and fibrosis in nonalcoholic steatohepatitis: therapeutic potential of dual peroxisome proliferator-activated receptor alpha/delta agonism
- (2013) Pablo Quintero et al. HEPATOLOGY
- Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
- (2013) Bart Staels et al. HEPATOLOGY
- DNA methylation patterns of peroxisome proliferator-activated receptor gamma gene associated with liver fibrosis and inflammation in chronic hepatitis B
- (2013) Q. Zhao et al. JOURNAL OF VIRAL HEPATITIS
- Telmisartan, an AT1 receptor blocker and a PPAR gamma activator, alleviates liver fibrosis induced experimentally by Schistosoma mansoni infection
- (2013) Yasmeen M Attia et al. Parasites & Vectors
- Nanomedicines of Hedgehog Inhibitor and PPAR-γ Agonist for Treating Liver Fibrosis
- (2013) Virender Kumar et al. PHARMACEUTICAL RESEARCH
- Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside
- (2012) Feng Zhang et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Couple Dynamics: PPARγ and Its Ligand Partners
- (2012) Shanghai Yu et al. STRUCTURE
- Peroxisome proliferator-activated receptor-γ cross-regulation of signaling events implicated in liver fibrogenesis
- (2011) Feng Zhang et al. CELLULAR SIGNALLING
- Peroxisome proliferator-activated receptor gamma inhibits hepatic fibrosis in rats
- (2011) Zheng Wang et al. Hepatobiliary & Pancreatic Diseases International
- Rosmarinic acid and baicalin epigenetically derepress peroxisomal proliferator-activated receptor γ in hepatic stellate cells for their antifibrotic effect
- (2011) Melissa D. Yang et al. HEPATOLOGY
- Effectiveness of the PPARγ agonist, GW570, in liver fibrosis
- (2010) Liu Yang et al. INFLAMMATION RESEARCH
- Peroxisome proliferator-activated receptors gamma reverses hepatic nutritional fibrosis in mice and suppresses activation of hepatic stellate cells in vitro
- (2010) Jun Yu et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Protective effects of baicalin on carbon tetrachloride induced liver injury by activating PPARγ and inhibiting TGFβ1
- (2010) Hongxiang Qiao et al. PHARMACEUTICAL BIOLOGY
- Vitamin C deficiency attenuates liver fibrosis by way of up-regulated peroxisome proliferator-activated receptor-gamma expression in senescence marker protein 30 knockout mice
- (2009) Jin-Kyu Park et al. HEPATOLOGY
- PI-3 K/AKT and ERK signaling pathways mediate leptin-induced inhibition of PPARγ gene expression in primary rat hepatic stellate cells
- (2009) Yajun Zhou et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- 15-Deoxy-Δ12,14-prostaglandin J2 inhibits fibrogenic response in human hepatoma cells
- (2009) Fat-Moon Suk et al. TOXICOLOGY LETTERS
- Rosiglitazone prevents murine hepatic fibrosis induced by Schistosoma japonicum
- (2008) Hui Chen et al. WORLD JOURNAL OF GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now